Thermo Fisher Scientific buys drug ingredients maker Patheon for US$7.2bn
Thermo Fisher Scientific's acquisition of Patheon represents a 35% premium to the share price at Friday's close
Company
Thermo Fisher Scientific Inc
NYSE:TMO
Thermo Fisher Scientific Inc is engaged in serving science. The company’s Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease.
24 stories · page 2 of 2
Affymetrix buys time on takeover controversy
Affymetrix, the takeover target which controversially spurned a higher offer for the company this week, said on Wednesday its proposed shareholder meeting to approve an offer from Thermo Fisher Scientific will proceed with a vote delayed by
Hardware & electrical equipment
Premaitha Health receives backing from US giant
Premaitha's screening technology is set to supplant the technology used in pre-natal products marketed by Brahms, a subsidiary of Thermo Fisher.